Terminal sales expand channels downward, Sanyou Medical's net profit in 2025 increases by 451.85%

NightAirdropper · 2026-02-28T06:58:45+00:00

Sanyou Medical releases 2025 performance forecast, with annual operating revenue of 542.7925 million yuan, a year-on-year increase of 19.66%; net profit of 63.2895 million yuan, a year-on-year increase of 451.85%. The main reasons are the continuous growth of the orthopedic business and the enhancement of international operations. At the same time, the implementation of an equity incentive plan led to an increase in share-based payment expenses.

NightAirdropper

2026-02-28 06:58:45

Abstract generation in progress

On February 26, Sanyou Medical (688085.SH) released its 2025 annual performance forecast, reporting total operating revenue of 542.79 million yuan, up 19.66% from 453.60 million yuan in the same period last year; total profit of 56.06 million yuan, up 155.92% from 21.90 million yuan; net profit attributable to shareholders of the listed company of 63.29 million yuan, up 451.85% from 11.47 million yuan; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 49.67 million yuan, turning from a loss of 3.78 million yuan last year; basic earnings per share of 0.19 yuan, up from 0.04 yuan last year, a 375% increase.

The main reasons for the performance change include: as the company’s terminal sales continue to expand and channels deepen, orthopedic business revenue remains stable and growing. Meanwhile, the combined revenue of Shuimu Tianpeng increased by 38.85% year-over-year, with net profit also significantly rising. Additionally, the company’s international business revenue has grown notably, with the controlling company Implanet’s revenue increasing by 32.62% year-over-year in 2025. Furthermore, during the reporting period, the company launched an equity incentive plan, recognizing share-based payment expenses of approximately 8.40 million yuan, while also provisioning approximately 34 million yuan for asset impairment losses and credit impairment losses.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.